Article
A recombinant human SLPI variant suppresses the formation of neutrophil extracellular traps at low concentrations in vitro.
Protein expression and purification - 1 Aug 2025
Jesus Gonzalez-Contreras Felipe de, Gutierrez-Vidal Roxana Guadalupe, Zarate Xristo
Abstract excerpt
Neutrophil extracellular traps (NETs) are web-like structures released by neutrophils to trap and kill microbes. While NETs are crucial in host defense, excessive formation can lead to autoimmune diseases. Currently, no specific drugs target NETs directly; however, some medications can indirectly modulate their formation. The secretory leukocyte protease inhibitor (SLPI) is a small protein that inhibits the...
Read the complete abstract on PubMedTopics
- Escherichia coli
- Humans
- Recombinant Proteins
- Secretory Leukocyte Peptidase Inhibitor
- Genetic Variation
- Extracellular Traps
